TNXP Earnings & Financial Statements - Tonix Pharmaceuticals Holding Corp. logo

TNXP Earnings & Financial Statements

Tonix Pharmaceuticals Holding Corp.

$2.55
-$0.27(-9.57%)
37
Overall
60
Value
9
Tech
44
Quality
How is this score calculated?
Market Cap
$49.55M
Volume
884.64K
52W Range
$2.90 - $20.56
Target Price
$32.00

TNXP earnings and financial statements: Tonix Pharmaceuticals Holding Corp.'s income statement, balance sheet and cash flow statement, annual and quarterly.

TNXP Annual Financial Statements

TNXP income statement
Fiscal year20252024202320222021
Revenue$13.11M$10.09M$7.77M--
Cost of revenue$6.64M$7.76M$4.74M--
Operating income-$122.69M-$136.70M-$118.38M-$112.09M-$92.31M
EBITDA-$122.01M-$124.54M-$112.37M-$110.84M-$92.26M
Net income-$124.02M-$130.04M-$116.66M-$110.22M-$92.29M
EPS (diluted)$-14.57$-176.60$-21888.00$-65400.00$-166400.00
TNXP balance sheet
Fiscal year20252024202320222021
Total assets$277.17M$162.89M$154.46M$225.69M$240.90M
Total liabilities$32.02M$23.33M$48.93M$18.51M$22.18M
Shareholders’ equity$245.15M$139.56M$105.53M$207.18M$218.72M
Cash and equivalents$207.64M$98.78M$24.95M$120.23M$178.66M
Long-term debt$1.18M$5.03M$7.19M$328.0K$467.0K
TNXP cash flow statement
Fiscal year20252024202320222021
Operating cash flow-$99.84M-$60.92M-$102.00M-$98.05M-$75.56M
Capital expenditure-$3.37M-$120.0K-$7.89M-$48.15M-$35.31M
Free cash flow-$103.21M-$61.05M-$109.90M-$146.20M-$110.86M
ABCD
1SymbolPriceChangeVol
2TNXP$2.55-9.6%884.64K
3
4
5
6

Get Tonix Pharmaceuticals Holding Corp. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.